-

Biogennix Launches OsteoSPAN Fiber Matrix

IRVINE, Calif.--(BUSINESS WIRE)--Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for bone fusion procedures, today announced the launch of its new OsteoSPAN Fiber Matrix.

Consisting of 100% demineralized cortical fibers, OsteoSPAN Fiber Matrix has been engineered for optimized handling, while providing verified osteoinductive potential and an osteoconductive scaffold that supports cellular bone formation and stimulates fusion. OsteoSPAN Fiber Matrix is also processed to provide rapid, consistent hydration and fluid retention while resisting irrigation.

The OsteoSPAN Fiber Matrix is moldable and cohesive when hydrated with blood or bone marrow, and expands to conform irregular bone voids. The product is available in 1cc, 2.5cc, 5cc and 10cc volumes.

“OsteoSPAN Fiber Matrix is Biogennix’ first allograft product,” said Biogennix CTO Mark Borden. “We’re excited to expand our portfolio to include allografts, which will complement our comprehensive synthetic offering and allow us to access a new segment of the bone graft market.”

Biogennix® is a fully-integrated osteobiologics company headquartered in Irvine which develops, manufactures, and distributes proprietary bone grafting products used in bone fusion procedures. Biogennix is committed to advancing technology behind natural bone grafting solutions, delivering outstanding quality with exceptional value, and customer-focused excellence. Learn more at biogennix.com.

Contacts

Paul Williams, 310-569-0023, paul@medialinecommunications.com

Biogennix


Release Versions

Contacts

Paul Williams, 310-569-0023, paul@medialinecommunications.com

Social Media Profiles
More News From Biogennix

Biogennix Launches Agilon Surgical Matrix

IRVINE, Calif.--(BUSINESS WIRE)--Biogennix, an osteobiologics company specializing in innovative healing solutions for surgical procedures, has announced the launch of its new Agilon Surgical Matrix wound care product. Agilon Surgical Matrix is a wound care solution derived from 100% bovine Type 1 collagen. Upon contact with a new or open wound, whether surgically or naturally occurring, Agilon Surgical Matrix transforms into a gel, enveloping the entire wound area. This coverage maintains a lo...

Biogennix Announces Publication of a Scientific Study on Its Advanced Bone Graft Technology

IRVINE, Calif.--(BUSINESS WIRE)--Biogennix, an osteobiologics company specializing in products for bone graft procedures, has announced the publication of a detailed scientific study characterizing multiple advanced properties of its TrelCor bone graft material. TrelCor is an innovative dual-phase bone graft featuring a nanocrystalline hydroxycarbanoapatite (HCA) surface, specially engineered for bone formation. The study, titled “Characterization of an Advanced Bone Graft Material with a Nanoc...

Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable and Morpheus Moldable Products

IRVINE, Calif.--(BUSINESS WIRE)--Irvine-based Biogennix, LLC an osteobiologics company specializing in bone graft products for fusion procedures, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication for its Agilon Moldable and Morpheus Moldable bone grafting products. The new clearance allows the products to be used in the intervertebral disc space as an autograft extender, with an FDA-cleared intervertebral body fusion device...
Back to Newsroom